The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preventable patient acute mortality after EMR-generated QTc alerts.
 
Benjamin Aaron Bleiberg
No Relationships to Disclose
 
Jingsheng Yan
No Relationships to Disclose
 
Donglu Xie
No Relationships to Disclose
 
Tammy Lightfoot
No Relationships to Disclose
 
Hong Zhu
No Relationships to Disclose
 
Joan Reisch
No Relationships to Disclose
 
David Sher
No Relationships to Disclose
 
Alvin Chandra
No Relationships to Disclose
 
Stephanie Terauchi
No Relationships to Disclose
 
David E. Gerber
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Samsung Bioepis
Research Funding - AstraZeneca (Inst); BerGenBio (Inst); Karyopharm Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending: “Prediction and Treatment of Immunotherapeutic Toxicity” (provisional, application number 62/461,455) (Inst); Royalties from Decision Support in Medicine from the Clinical Decision Support--Oncology on-line program.; Royalties from Oxford University Press from two books.
 
Saad A. Khan
Honoraria - ARIAD; EMD Serono; Genentech/Roche; Genzyme
Consulting or Advisory Role - ARIAD; Bayer/Onyx; Bayer/Onyx; EMD Serono; Foundation Medicine; Genentech/Roche; Guardant Health; Oak Ridge Associated Universities; Takeda
Speakers' Bureau - Genzyme; Takeda
Research Funding - Abbvie (Inst); Bayer/Onyx (Inst); Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Formation Biologics (Inst); Genentech (Inst); Gilead Sciences (Inst); Guardant Health (Inst); Loxo (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Threshold Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Genentech; Novartis